CLEVER CULTURE SYSTEMS LIMITED - Announcements

2.86%

3.6¢

Market Cap $65.33M

Healthcare Biotechnology

Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based... Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based company that provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence (AI) and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates. The technology is a United States FDA-cleared AI technology for automated culture plate reading. The product is being sold to microbiology laboratories in the pharmaceutical manufacturing sector for the reading of environmental monitoring culture plates and to clinical laboratories as an in vitro diagnostic for infectious diseases. Thermo Fisher Scientific, Inc is the exclusive distributor of the APAS Independence to clinical customers in the United States and selected countries in Europe.More

Announcements

Filter Results

All Price Sensitive Only

CC5	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/19	291.44KB	Share
CC5	Timing of Quarterly Results & Investor Call		25/07/19	129.04KB	Share
CC5	Update on Distributor Appointments	PRICE SENSITIVE	22/07/19	140.02KB	Share
CC5	Share Trading Policy		28/06/19	208.17KB	Share
CC5	South Australian Government Loan $1.5M Drawdown	PRICE SENSITIVE	27/06/19	131.69KB	Share
CC5	First U.S. Clinical Data with APAS Presented at ASM Microbe	PRICE SENSITIVE	24/06/19	658.03KB	Share
CC5	US Market Update	PRICE SENSITIVE	19/06/19	132.39KB	Share
CC5	Notice under Section 708A		11/06/19	85.31KB	Share
CC5	Information Required Under ASX Listing Rule 3.10.5A	PRICE SENSITIVE	11/06/19	111.28KB	Share
CC5	Appendix 3B		11/06/19	409.2KB	Share
CC5	$5M Oversubscribed Private Placement	PRICE SENSITIVE	05/06/19	1.46MB	Share
CC5	Trading Halt	PRICE SENSITIVE	03/06/19	292.92KB	Share
CC5	APAS Independence Receives US FDA 510(k) Clearance	PRICE SENSITIVE	20/05/19	442.5KB	Share
CC5	Trading Halt	PRICE SENSITIVE	17/05/19	157.96KB	Share
CC5	AusMedtech & ANDHealth Conferences		15/05/19	130.08KB	Share
CC5	South Australian Government Loan - $1.0M Drawdown	PRICE SENSITIVE	09/05/19	130.71KB	Share
CC5	Business Update Presentation	PRICE SENSITIVE	30/04/19	2.58MB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/19	289.35KB	Share
CC5	Timing of Quarterly Results & Investor Call		24/04/19	129.14KB	Share
CC5	APAS Independence MRSA Study Results Presented at ECCMID	PRICE SENSITIVE	15/04/19	296.45KB	Share
CC5	MRSA Analysis Module - Clinical Study Commenced	PRICE SENSITIVE	02/04/19	133.9KB	Share
CC5	Change of Director's Interest Notice		01/04/19	150.96KB	Share
CC5	Initial Director's Interest Notice		25/03/19	188.26KB	Share
CC5	Change of Director's Interest Notice		22/03/19	153.26KB	Share
CC5	Final Director's Interest Notice		04/03/19	136.89KB	Share
CC5	Change of Director's Interest Notice		04/03/19	147.76KB	Share
CC5	Non-Executive Director Changes		01/03/19	129.21KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/19	707.66KB	Share
CC5	Details of Investor Call - 6 February 2019		05/02/19	125.08KB	Share
CC5	Initial Director's Interest Notice		04/02/19	176.32KB	Share
CC5	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/19	292.43KB	Share
CC5	Appointment US Based Non-Executive Director Simon Arkell		30/01/19	134.35KB	Share
CC5	US FDA 510k Submitted for APAS Independence	PRICE SENSITIVE	21/12/18	139.09KB	Share
CC5	LBT Receives $1.9 Million R&D Tax Incentive	PRICE SENSITIVE	20/12/18	102.45KB	Share
CC5	Expiration of Options		10/12/18	92.72KB	Share
CC5	LBT Presentation - 121 Tech Investment Conference, Singapore	PRICE SENSITIVE	03/12/18	1.99MB	Share
CC5	Expiration of Options		03/12/18	93.06KB	Share
CC5	Results of Meeting		28/11/18	100.83KB	Share
CC5	CEO Presentation - AGM 2018	PRICE SENSITIVE	28/11/18	1.62MB	Share
CC5	Chairman's Address to Shareholders	PRICE SENSITIVE	28/11/18	94.4KB	Share
CC5	First Placement of APAS Independence into US Lab	PRICE SENSITIVE	26/11/18	123.82KB	Share
CC5	Australian Sales Update	PRICE SENSITIVE	26/11/18	118.52KB	Share
CC5	Quarterly Activities & Cashflow Report - Appendix 4C	PRICE SENSITIVE	31/10/18	410.92KB	Share
CC5	Notice of Annual General Meeting/Proxy Form		26/10/18	487.77KB	Share
CC5	Final Director's Interest Notice		23/10/18	216.2KB	Share
CC5	Change of Director's Interest Notice		23/10/18	168.42KB	Share
CC5	Cancellation of Options		23/10/18	93.67KB	Share
CC5	Non-Executive Director Resignation		22/10/18	77.11KB	Share
CC5	Correction to 2018 Annual Report		04/10/18	3.17MB	Share
CC5	Appendix 4G		27/09/18	268.44KB	Share
CC5	Corporate Governance Statement		27/09/18	251.37KB	Share
CC5	Annual Report to shareholders		27/09/18	6.57MB	Share
CC5	Company Presentation - Australian Non Deal Roadshow	PRICE SENSITIVE	17/09/18	1.97MB	Share
CC5	Preliminary Final Report	PRICE SENSITIVE	30/08/18	1.3MB	Share
CC5	Finalisation of SA Government Loan Facility Agreement	PRICE SENSITIVE	28/08/18	142.02KB	Share
CC5	First Commercial Sale of APAS Independence	PRICE SENSITIVE	22/08/18	143.72KB	Share
CC5	Details of Investor Call - 15 August 2018		14/08/18	133.29KB	Share
CC5	Quarterly Activities & Cash Flow Report - Appendix 4C	PRICE SENSITIVE	30/07/18	444.53KB	Share
CC5	Presentation at 14th Bioshares Biotech Summit		27/07/18	1.7MB	Share
CC5	Market Update	PRICE SENSITIVE	29/06/18	47.64KB	Share
CC5	Presentation of APAS at ASM Microbe		07/06/18	164.1KB	Share
CC5	Strategic Plan & Asset Review, WoundVue	PRICE SENSITIVE	06/06/18	166.01KB	Share
CC5	Investor Presentation		04/06/18	1.74MB	Share
CC5	Notice Under Section 708A		14/05/18	54.17KB	Share
CC5	Appendix 3B		14/05/18	200.2KB	Share
CC5	Completion of Private Placement $7.9M Raised with SPP		14/05/18	134.93KB	Share
CC5	Ceasing to be a substantial holder		09/05/18	49.88KB	Share
CC5	Ceasing to be a substantial holder		07/05/18	107.53KB	Share
CC5	Quarterly Investor Call Details		07/05/18	136.63KB	Share
CC5	Change of Director's Interest Notice		03/05/18	112.75KB	Share
CC5	Change of Director's Interest Notice		03/05/18	113.16KB	Share
CC5	Change of Director's Interest Notice		03/05/18	114.44KB	Share
CC5	Change of Director's Interest Notice		03/05/18	114.31KB	Share
CC5	Change of Director's Interest Notice		03/05/18	113.67KB	Share
CC5	Change of Director's Interest Notice		03/05/18	114.11KB	Share
CC5	Notice Under Section 708A		27/04/18	111.51KB	Share
CC5	Appendix 3B		27/04/18	199.58KB	Share
CC5	Appendix 3B		26/04/18	199.56KB	Share
CC5	Quarterly Activities & Cash Flow Report - Appendix 4C	PRICE SENSITIVE	26/04/18	444.09KB	Share
CC5	First Placement of APAS Independence into European Lab	PRICE SENSITIVE	24/04/18	175.82KB	Share
CC5	Presentation of APAS Evaluation at 28th ECCMID Conference		23/04/18	862.95KB	Share
CC5	EGM - Results of Meeting		18/04/18	122.11KB	Share
CC5	EGM - CEO Presentation		18/04/18	783.5KB	Share
CC5	Appendix 3B		10/04/18	199.33KB	Share
CC5	Share Purchase Plan Raises $0.49M		06/04/18	105.63KB	Share
CC5	Notice of Extraordinary General Meeting/Proxy Form		16/03/18	472.28KB	Share
CC5	Share Purchase Plan Offer Document	PRICE SENSITIVE	14/03/18	1.12MB	Share
CC5	NOTICE UNDER SECTION 708A		12/03/18	109.93KB	Share
CC5	Information under Listing Rule 3.10.5A		12/03/18	111.15KB	Share
CC5	Appendix 3B		12/03/18	720.65KB	Share
CC5	$7m Oversubscribed Private Placement & Launch of $1m SPP	PRICE SENSITIVE	06/03/18	2.18MB	Share
CC5	Trading Halt	PRICE SENSITIVE	02/03/18	116.35KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/18	901.82KB	Share
CC5	LBT Receives $4m Funding from South Australian Government	PRICE SENSITIVE	19/02/18	167.3KB	Share
CC5	Quarterly Activities & Cash Flow Report (Appendix 4C)	PRICE SENSITIVE	29/01/18	440.74KB	Share
CC5	LBT Presentation JP Morgan Biotech Showcase		08/01/18	8.59MB	Share
CC5	$2.5M Grant Awarded to Advance WoundVue Development	PRICE SENSITIVE	07/12/17	176.58KB	Share
CC5	Appendix 3B		04/12/17	193.79KB	Share
CC5	Change of Director's Interest Notice		01/12/17	262.36KB	Share
CC5	Change of Director's Interest Notice		01/12/17	260.61KB	Share

CC5 Appendix 4C - quarterly
29/07/19	PRICE SENSITIVE	291.44KB	Share
CC5 Timing of Quarterly Results & Investor Call
25/07/19		129.04KB	Share
CC5 Update on Distributor Appointments
22/07/19	PRICE SENSITIVE	140.02KB	Share
CC5 Share Trading Policy
28/06/19		208.17KB	Share
CC5 South Australian Government Loan $1.5M Drawdown
27/06/19	PRICE SENSITIVE	131.69KB	Share
CC5 First U.S. Clinical Data with APAS Presented at ASM Microbe
24/06/19	PRICE SENSITIVE	658.03KB	Share
CC5 US Market Update
19/06/19	PRICE SENSITIVE	132.39KB	Share
CC5 Notice under Section 708A
11/06/19		85.31KB	Share
CC5 Information Required Under ASX Listing Rule 3.10.5A
11/06/19	PRICE SENSITIVE	111.28KB	Share
CC5 Appendix 3B
11/06/19		409.2KB	Share
CC5 $5M Oversubscribed Private Placement
05/06/19	PRICE SENSITIVE	1.46MB	Share
CC5 Trading Halt
03/06/19	PRICE SENSITIVE	292.92KB	Share
CC5 APAS Independence Receives US FDA 510(k) Clearance
20/05/19	PRICE SENSITIVE	442.5KB	Share
CC5 Trading Halt
17/05/19	PRICE SENSITIVE	157.96KB	Share
CC5 AusMedtech & ANDHealth Conferences
15/05/19		130.08KB	Share
CC5 South Australian Government Loan - $1.0M Drawdown
09/05/19	PRICE SENSITIVE	130.71KB	Share
CC5 Business Update Presentation
30/04/19	PRICE SENSITIVE	2.58MB	Share
CC5 Appendix 4C - quarterly
29/04/19	PRICE SENSITIVE	289.35KB	Share
CC5 Timing of Quarterly Results & Investor Call
24/04/19		129.14KB	Share
CC5 APAS Independence MRSA Study Results Presented at ECCMID
15/04/19	PRICE SENSITIVE	296.45KB	Share
CC5 MRSA Analysis Module - Clinical Study Commenced
02/04/19	PRICE SENSITIVE	133.9KB	Share
CC5 Change of Director's Interest Notice
01/04/19		150.96KB	Share
CC5 Initial Director's Interest Notice
25/03/19		188.26KB	Share
CC5 Change of Director's Interest Notice
22/03/19		153.26KB	Share
CC5 Final Director's Interest Notice
04/03/19		136.89KB	Share
CC5 Change of Director's Interest Notice
04/03/19		147.76KB	Share
CC5 Non-Executive Director Changes
01/03/19		129.21KB	Share
CC5 Half Yearly Report and Accounts
26/02/19	PRICE SENSITIVE	707.66KB	Share
CC5 Details of Investor Call - 6 February 2019
05/02/19		125.08KB	Share
CC5 Initial Director's Interest Notice
04/02/19		176.32KB	Share
CC5 Appendix 4C - quarterly
31/01/19	PRICE SENSITIVE	292.43KB	Share
CC5 Appointment US Based Non-Executive Director Simon Arkell
30/01/19		134.35KB	Share
CC5 US FDA 510k Submitted for APAS Independence
21/12/18	PRICE SENSITIVE	139.09KB	Share
CC5 LBT Receives $1.9 Million R&D Tax Incentive
20/12/18	PRICE SENSITIVE	102.45KB	Share
CC5 Expiration of Options
10/12/18		92.72KB	Share
CC5 LBT Presentation - 121 Tech Investment Conference, Singapore
03/12/18	PRICE SENSITIVE	1.99MB	Share
CC5 Expiration of Options
03/12/18		93.06KB	Share
CC5 Results of Meeting
28/11/18		100.83KB	Share
CC5 CEO Presentation - AGM 2018
28/11/18	PRICE SENSITIVE	1.62MB	Share
CC5 Chairman's Address to Shareholders
28/11/18	PRICE SENSITIVE	94.4KB	Share
CC5 First Placement of APAS Independence into US Lab
26/11/18	PRICE SENSITIVE	123.82KB	Share
CC5 Australian Sales Update
26/11/18	PRICE SENSITIVE	118.52KB	Share
CC5 Quarterly Activities & Cashflow Report - Appendix 4C
31/10/18	PRICE SENSITIVE	410.92KB	Share
CC5 Notice of Annual General Meeting/Proxy Form
26/10/18		487.77KB	Share
CC5 Final Director's Interest Notice
23/10/18		216.2KB	Share
CC5 Change of Director's Interest Notice
23/10/18		168.42KB	Share
CC5 Cancellation of Options
23/10/18		93.67KB	Share
CC5 Non-Executive Director Resignation
22/10/18		77.11KB	Share
CC5 Correction to 2018 Annual Report
04/10/18		3.17MB	Share
CC5 Appendix 4G
27/09/18		268.44KB	Share
CC5 Corporate Governance Statement
27/09/18		251.37KB	Share
CC5 Annual Report to shareholders
27/09/18		6.57MB	Share
CC5 Company Presentation - Australian Non Deal Roadshow
17/09/18	PRICE SENSITIVE	1.97MB	Share
CC5 Preliminary Final Report
30/08/18	PRICE SENSITIVE	1.3MB	Share
CC5 Finalisation of SA Government Loan Facility Agreement
28/08/18	PRICE SENSITIVE	142.02KB	Share
CC5 First Commercial Sale of APAS Independence
22/08/18	PRICE SENSITIVE	143.72KB	Share
CC5 Details of Investor Call - 15 August 2018
14/08/18		133.29KB	Share
CC5 Quarterly Activities & Cash Flow Report - Appendix 4C
30/07/18	PRICE SENSITIVE	444.53KB	Share
CC5 Presentation at 14th Bioshares Biotech Summit
27/07/18		1.7MB	Share
CC5 Market Update
29/06/18	PRICE SENSITIVE	47.64KB	Share
CC5 Presentation of APAS at ASM Microbe
07/06/18		164.1KB	Share
CC5 Strategic Plan & Asset Review, WoundVue
06/06/18	PRICE SENSITIVE	166.01KB	Share
CC5 Investor Presentation
04/06/18		1.74MB	Share
CC5 Notice Under Section 708A
14/05/18		54.17KB	Share
CC5 Appendix 3B
14/05/18		200.2KB	Share
CC5 Completion of Private Placement $7.9M Raised with SPP
14/05/18		134.93KB	Share
CC5 Ceasing to be a substantial holder
09/05/18		49.88KB	Share
CC5 Ceasing to be a substantial holder
07/05/18		107.53KB	Share
CC5 Quarterly Investor Call Details
07/05/18		136.63KB	Share
CC5 Change of Director's Interest Notice
03/05/18		112.75KB	Share
CC5 Change of Director's Interest Notice
03/05/18		113.16KB	Share
CC5 Change of Director's Interest Notice
03/05/18		114.44KB	Share
CC5 Change of Director's Interest Notice
03/05/18		114.31KB	Share
CC5 Change of Director's Interest Notice
03/05/18		113.67KB	Share
CC5 Change of Director's Interest Notice
03/05/18		114.11KB	Share
CC5 Notice Under Section 708A
27/04/18		111.51KB	Share
CC5 Appendix 3B
27/04/18		199.58KB	Share
CC5 Appendix 3B
26/04/18		199.56KB	Share
CC5 Quarterly Activities & Cash Flow Report - Appendix 4C
26/04/18	PRICE SENSITIVE	444.09KB	Share
CC5 First Placement of APAS Independence into European Lab
24/04/18	PRICE SENSITIVE	175.82KB	Share
CC5 Presentation of APAS Evaluation at 28th ECCMID Conference
23/04/18		862.95KB	Share
CC5 EGM - Results of Meeting
18/04/18		122.11KB	Share
CC5 EGM - CEO Presentation
18/04/18		783.5KB	Share
CC5 Appendix 3B
10/04/18		199.33KB	Share
CC5 Share Purchase Plan Raises $0.49M
06/04/18		105.63KB	Share
CC5 Notice of Extraordinary General Meeting/Proxy Form
16/03/18		472.28KB	Share
CC5 Share Purchase Plan Offer Document
14/03/18	PRICE SENSITIVE	1.12MB	Share
CC5 NOTICE UNDER SECTION 708A
12/03/18		109.93KB	Share
CC5 Information under Listing Rule 3.10.5A
12/03/18		111.15KB	Share
CC5 Appendix 3B
12/03/18		720.65KB	Share
CC5 $7m Oversubscribed Private Placement & Launch of $1m SPP
06/03/18	PRICE SENSITIVE	2.18MB	Share
CC5 Trading Halt
02/03/18	PRICE SENSITIVE	116.35KB	Share
CC5 Half Yearly Report and Accounts
26/02/18	PRICE SENSITIVE	901.82KB	Share
CC5 LBT Receives $4m Funding from South Australian Government
19/02/18	PRICE SENSITIVE	167.3KB	Share
CC5 Quarterly Activities & Cash Flow Report (Appendix 4C)
29/01/18	PRICE SENSITIVE	440.74KB	Share
CC5 LBT Presentation JP Morgan Biotech Showcase
08/01/18		8.59MB	Share
CC5 $2.5M Grant Awarded to Advance WoundVue Development
07/12/17	PRICE SENSITIVE	176.58KB	Share
CC5 Appendix 3B
04/12/17		193.79KB	Share
CC5 Change of Director's Interest Notice
01/12/17		262.36KB	Share
CC5 Change of Director's Interest Notice
01/12/17		260.61KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.6¢		Change 0.001(2.86%)		Mkt cap ! $65.33M

Open	High	Low	Value	Volume
3.5¢	3.6¢	3.5¢	$18.02K	513.3K

Buyers (Bids)

No.	Vol.	Price($)
7	991682	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	1072927	5

View Market Depth

No.	Vol.	Price($)
7	991682	0.034
6	971865	0.033
4	504275	0.032
1	32258	0.031
4	618150	0.030

Price($)	Vol.	No.
0.036	1072927	5
0.037	1353817	1
0.039	1128436	4
0.040	3000000	2
0.041	300000	1

Last trade - 15.55pm 21/08/2025 (20 minute delay)


Last 3.6¢		Change 0.001 ( 2.86 %)
Open	High	Low	Volume
3.5¢	3.6¢	3.5¢	84104
Last updated 15.55pm 21/08/2025 ?

CC5 (ASX) Chart

CLEVER CULTURE SYSTEMS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories